NIDDK U01 - Prevention of Lower Urinary Tract Symptoms in Women
The National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK) is pleased to announce the release of two new funding announcements titled “Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Clinical Centers (PLUS-CCs) (U01)” and “Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Scientific and Data Coordinating Center (PLUS -SDCC) (U01).”
This Funding Opportunity Announcement (FOA) invites cooperative agreement research applications to establish a multi-center, multi-disciplinary consortium to be known as the Prevention of Lower Urinary tract Symptoms (PLUS) Research Consortium. This FOA expands NIH's research emphasis from treatment of women with established lower urinary tract symptoms (LUTS) to prevention of LUTS. At present there is insufficient information to undertake large-scale primary and secondary LUTS prevention efforts. The primary objective of this FOA is to plan, perform and analyze the research studies necessary to establish the scientific basis for future prevention intervention studies for lower urinary tract symptoms and conditions in women. The consortium will develop the evidence base for normal or healthy bladder function in females from adolescent girls to older non-institutionalized women to identify behavioral and other risk factors for conditions associated with LUTS with a particular focus on symptoms that are associated with the diagnosis of bladder infections, urinary incontinence, voiding dysfunction, overactive bladder and interstitial cystitis/bladder pain syndrome.
The application due date is November 20, 2014. Please be advised that, although not required, a letter of intent is strongly encouraged to be received by KUH by October 20, 2014. To request additional information, please contact Dr. Tamara Bavendam at email@example.com.
Abstract Submission Site is NOW OPEN for AUA2015
Submit your abstract for the 2015 AUA Annual Meeting, to be held May 15 – 19, 2015 in the dynamic city of New Orleans, LA. Access information about abstract submissions. Reserve your housing now for AUA2015.
Register Now - SBUR Fall Symposium
The Society for Basic Urologic Research presents the 2014 Fall Symposium Omics in Urologic Research – New Frontiers Driving Precision Medicine, November 13 – 16, 2014 at the Hilton Anatole in Dallas, Texas.
This three day program focuses on “omics” technologies and how they have impacted our understanding of urologic disease. The 2014 Special Invited Lecturers Include: Haifan Lin, PhD the Leland W.K. Chung Lecturer and Ian Thompson, MD, the AUA Lecturer. Plenary Sessions Include: Omics: Drivers from Bench to Bedside; Emerging Transcriptomics and Novel Pathways; Models and Disparities in Urologic Diseases; Molecular Markers and Targets for Urologic Diseases and Emerging Treatment Strategies for Advanced Urologic Cancer. Earn 17.75 CME Credits.
View the Program and Register Now at www.SBUR.org. The early bird registration deadline is October 10, 2014!
Fall NIH Workshops - Diabetes Complications
The National Institutes of Health (NIH) will sponsor three workshops this fall that offer excellent opportunities to learn about the latest research in areas relevant to diabetes complications – host-microbiota interactions, small vessel biology, and cardiovascular disease in type-1 diabetes.
Host-Microbiota Interactions: How Host Physiology and Disease Pathophysiology Are Affected by the Gut Microbiota
Sept. 8 and 9, 2014
Sponsored by NIDDK
Small Blood Vessels: Big Health Problems
Sept. 18 and 19, 2014
Sponsored by the Trans-NIH Small Vessel Biology Working Group (NINDS, NHLBI, NEI, ODP and ORWH)
Cardiovascular Disease and Type-1 Diabetes
October 8 and 9, 2014
Sponsored by NIDDK and NHLBI
2014 Prostate Cancer Foundation Global Treatment Sciences Challenge Award
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for lethal prostate cancer. Approximately 5-10 Challenge Awards will be funded depending on level of innovation in applications received. High risk, first-in-field and currently unfunded projects are most desired.
PCF Challenge Awards support large-scale team science research projects concerning lethal prostate cancer over the duration of 2-3 years, provide up to a total of $1,000,000 per team and cover direct research costs only. This award will support the correlative research around either clinical trials of novel agents or strategies of standard of care. One emphasis is on developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanism by which therapies work. While the focus is on research in humans, the actual trials or treatments themselves will not be supported. Human samples are highly preferred, although at times, model systems might be required to complement the understanding of an important mechanism.
Please refer to the RFA for details on eligibility requirements and application submission guidelines.
The online application submission form will go live at http://www.pcfscience.org after July 22, 2014. The deadline for application submission is September 22, 2014.
The Ann Arbor Urological Health Services Research Symposium 2014
On September 18-19, 2014, the University Of Michigan Department Of Urology will host the 2nd Ann Arbor Urological Health Services Research Symposium. Building on the highly successful initial symposium held in 2012, this program will gather experts in urological Health Services Research, as well as national thought leaders in the social sciences to expand the boundaries of the current research agendas. To that end, the focus will be on opportunities for “big data" to improve healthcare quality. Additionally, there will be discussions regarding the implications of social networks on urological care and the roles of implementation science and quality improvement interventions to enhance care delivery. Please visit the website for more information.
AHRQ - Patient-Centered Outcomes (PCOR) Career Development Awards
The Agency for Healthcare Research and Quality announces its continued interest in supporting individual Patient Centered Outcomes Research (PCOR) career development awards. AHRQ has two Funding Opportunity Announcements (FOAs) currently accepting applications, which can be found at:
AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Investigator Award (K08) PA-13-180
AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Development Award (K01) PA-13-181
AUA Annual Census
The American Urological Association is continuing to collect data for its Annual Census! The AUA Census will, for the first time, explore the profession of urology from multiple angles in one systematically designed survey by collecting data from urologists and other urology professionals throughout the world.
The collection period for the 2014 Census is now closed. AUA members who complete the Census will receive a free copy of The State of Urology Workforce and Practice in the United States, which will be published in early 2015.
FDA to Host Workshop on Female Sexual Dysfunction
The Food and Drug Administration (FDA) is conducting a Patient-Focused Drug Development public meeting and scientific workshop on Female Sexual Dysfunction (FSD) on October 27 and October 28. This website will be updated as meeting materials are developed.
Date(s) and Time(s)
October 27, 2014 (12:00 p.m. to 5:00 p.m.)
October 28, 2014 (8:00 a.m. to 5:00 p.m.)
FDA White Oak Campus
10903 New Hampshire Avenue
Building 31, Room 1503 B and C
Silver Spring, MD 20993
(Information about arrival to FDA's White Oak campus)
Day 1 – October 27th Patient-Focused Drug Development Public Meeting
The FDA is interested in obtaining patient input on:
1. The impact of the most common form of FSD, female sexual interest/arousal disorder (FSIAD) on daily life
2. Patients’ views on currently available therapies to treat the condition
Day 2 – October 28th Scientific Workshop
The scientific workshop will include discussion on scientific challenges related to:
1. Diagnosis of the condition for clinical trials and in clinical practice
2. Ensuring valid patient-reported outcome measures for the key efficacy endpoints used in clinical trials
CDC Releases National Plan on Infertility
In July, the Centers for Disease Control and Prevention (CDC) released a new National Public Health Action Plan for the Detection, Prevention and Management of Infertility. Former AUA President Dr. Lawrence Ross participated in this initiative, and shares his thoughts in a new AUA Policy Blog Q&A.
NIH CSR Early Career Reviewer Program
The NIH Center for Scientific Review (CSR) Early Career Reviewer (ECR) program was developed to train qualified scientists without prior CSR review experience to become effective reviewers, help emerging researchers advance their careers by exposing them to peer review, and enrich the existing pool of NIH reviewers by including scientists from less research-intensive institutions as well as those from traditionally research-intensive institutions.
Applicants should be full-time faculty members or researchers in a similar role, show evidence of an active independent program of research, have recent senior authored research publications in peer-reviewed journals, and have not served on a CSR study section in a role other than a mail reviewer or ARRA reviewer. Prior NIH funding is not a requirement.
Further information regarding the program may be found here.
© 2017 American Urological Association Education and Research Inc. All Rights Reserved.